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Abstract
Epigenetic post-transcriptional modifications of histone tails are thought to help in coordinating gene expression during
development. An epigenetic signature is set in pluripotent cells and interpreted later at the onset of differentiation. In
pluripotent cells, epigenetic marks normally associated with active genes (H3K4me3) and with silent genes (H3K27me3)
atypically co-occupy chromatin regions surrounding the promoters of important developmental genes. However, it is
unclear how these epigenetic marks are recognized when cell differentiation starts and what precise role they play. Here, we
report the essential role of the nuclear receptor peroxisome proliferator-activated receptor b (PPARb, NR1C2) in Xenopus
laevis early development. By combining loss-of-function approaches, large throughput transcript expression analysis by the
mean of RNA-seq and intensive chromatin immunoprecipitation experiments, we unveil an important cooperation between
epigenetic marks and PPARb. During Xenopus laevis gastrulation PPARb recognizes H3K27me3 marks that have been
deposited earlier at the pluripotent stage to activate early differentiation genes. Thus, PPARbis the first identified
transcription factor that interprets an epigenetic signature of pluripotency, in vivo, during embryonic development. This
work paves the way for a better mechanistic understanding of how the activation of hundreds of genes is coordinated
during early development.
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Introduction
How a single egg cell divides and invariably produces all sorts of
differentiated cells that form the adult organism is the foundational
question of developmental biology. Because all the cells of the
organism share the same genome inherited from the zygote,
different epigenetic landscapes are the main distinctive genomic
feature of differentiated cells. This points to the important role of
heritable epigenetic marks such as DNA methylation, histone H3
tri-methylation on lysine 4 (H3K4me3) or on lysine 27
(H3K27me3) in the process of differentiation [1,2]. Epigenetic
marks not only contribute to the progression of cell differentiation,
they also help in coordinating the switch from pluripotency to
early differentiation. Indeed, an epigenetic signature is set in
pluripotent cells before the onset of differentiation. In cultured
embryonic stem cells (ESCs) and pluripotent stem cells, and the
developing fish embryo, ‘bivalent’ genes bear opposing epigenetic
marks in the vicinity of their promoter region: the activating
H3K4me3 and the repressive H3K27me3 [3,4]. These bivalent
genes mostly encode important developmental regulators
[3,5,6,7,8], and many are synchronously induced during cell
differentiation, concomitantly losing their repressive H3K27me3
mark [5,6,7,9]. This process is thus thought to facilitate a
coordinated wave of gene expression by identifying the few
hundred genes that are important for the very early differentiation
in the total repertoire of more than 20,000.
However, the relation between gene expression at the onset of
differentiation and bivalency is complex: many bivalent genes are
synchronously activated [3,5] while some others become repressed
[10]. Therefore, it is likely that other factors should be taken into
consideration, and in particular the transcription factors that
should interpret this epigenetic signature at the time of differen-
tiation. However, if common signal transducers are likely
implicated in H3K27me3 loss at bivalent genes during differen-
tiation in ESC, how specific genes are recognized is unclear and in
vivo knowledge is limited [11,12,13].
Here we report that the nuclear hormone receptor peroxisome
proliferator-activated receptor b (PPARb, NR1C2) can interpret
an epigenetic signature of pluripotency during Xenopus laevis
gastrulation.
PPARb is a ligand-activated transcription factor important for
cell differentiation in the adult [14] and in the placenta [15], but
its role in the embryo has not been studied properly. We show
that in Xenopus laevis, PPARb is essential for neural and muscle
differentiation as early as in gastrulation when a massive change
in transcript level occurs. By using genomic (RNA-seq) and
bioinformatics approaches we propose that PPARb preferentially
activates bivalent genes at gastrulation. This hypothesis is
supported by direct examination of developing Xenopus laevis
embryos using chromatin immunoprecipitation (ChIP). Most
importantly, pharmacologic manipulation of H3K27me3 levels in
the embryo indicates that it is this mark that triggers gene
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activation by PPARb. Our work represents an important step
towards a better understanding of the role of epigenetic marks in
the switch from pluripotent to differentiated state.
Materials and Methods
Animal care and housing
Animal care and handling procedures were approved by the
Commission de Surveillance de l’Expe´rimentation Animale of the
Canton de Vaud, Switzerland.
In vitro fertilization, embryo microinjections, and drug
treatments
X. laevis oocyte collection, fertilization, and de-jellying were
performed according to standard procedures [16]. Unless other-
wise indicated, injections were done at the 2-cell stage, with a
single injection in each of the two cells. 3-deazaneplanocin A
(DZNep) (Cayman) treatment: X. laevis embryos were injected with
Co or PPARb MO (morpholino) and allowed to develop until
stage 5 when DZNep or DMSO was added to the water. Embryos
were collected at stage 10.5 for RT-qPCR or ChIP with
H3K27me3 antibody.
RNA–seq
The paired-end tags with no more than 5 N in each pair were
mapped onto 10,691 distinct RefSeq X. laevis mRNA with
fetchGWI, which is part of the Tagger software suite [17], using
up to one mismatch per tag. Paired-end tags matching a unique
mRNA with a separation of 500 nt at most were retained as valid
hits (3.4 and 4.1 million for Co and MO, respectively). The
number of tags matching each mRNA was counted and taken as a
measure of the transcript abundance to compute relative
abundance of MO. We assumed that most of the genes would
be unaffected by the MO and multiplied the MO counts by 0.799
to obtain similar distribution counts between Co and MO. The
values for the adjusted lowest, 1st quartile, median, 3rd quartile,
and maximum number of tags were 1, 26, 99, 304, and 69,440 for
the control and 0.8, 26, 99, 305, and 67,990 for MO, respectively.
Additional technical information about functional analysis of
the RNA-seq is given in Protocol S1.
Antibodies
An affinity-purified polyclonal antibody against xenopus
PPARb was produced by immunizing rabbits with the peptide
KLH-VQAPVSDSAAPDSPV (Eurogentec). This antibody de-
tected a 45-kDa protein after immunoblotting of whole-embryo
extracts (Fig. S1B). Moreover, a band migrating at the same
position was detected when PPAR proteins were pooled-down
using a DNA_biotinylated probe containing three copies in
tandem of the peroxisome proliferator-activated receptor response
element (3xPPRE motif). This band corresponded to PPARb
because PPARa and PPARc have an expected mass of about
50 kDa and because the efficiency of the pull-down increased
when GW501516, a selective PPARb agonist, was added (Fig.
S1B).
We used anti-H3K4me3 from Abcam (ab8580), anti-
H3K27me3 from Millipore (07-449), and anti–b-actin from Sigma
(AC-40).
Immunoblotting/DNAP/ChIP
Protein extraction for immunoblotting was done according to
the De Robertis online protocol for phospho-proteins (Fuentealba;
http://www.hhmi.ucla.edu/derobertis/index.html). DNA affinity
purification was done according to [18] starting with the extract
from 15 embryos (stg. 12). The DNA probe was produced by
annealing the following primers: forward, BioTEG-CGTTCA-
GGTCAAAGGTCACGTTCAGGTCAAAGGTCACGTTCAG-
GTCAAAGGTCA and reverse, TGACCTTTGACCTGAAC-
GTGACCTTTGACCTGAACGTGACCTTTGACCTGAACG.
GW501516 or DMSO was added together with 10 ml of
equilibrated beads, and the extracts were left rotating for 30 min
at room temperature before proteins were pulled down and
processed for immunoblotting.
ChIP was done according to [19] but using Dynabeads protein
G (Invitrogen). For ChIP-reChIP, we proceeded as for ChIP with
150 embryos as starting material. After the TE buffer wash at the
end of the first IP, we eluted DNA/protein complexes in 75 ml of
TE/10 mM DTT buffer for 30 min at 37uC. The supernatant was
diluted 206with IP buffer. We then proceeded with the second IP,
as for a simple ChIP.
Input and immunoprecipitated DNA recovered after de-cross-
linking were purified using NucleoSpin Extract II (Macherey-
Nagel) and quantified by qPCR.
The percentage of input was calculated as follows:
Pinput = Egene
(CTinput_gene-CTsample_gene)*100
E stands for gene-specific efficiency and was calculated as
explained in the qPCR section below. Enrichment over a
negative control was calculated for each primer pair as the ratio
of the percentage of input of the IP over the percentage of input
of the negative control. For ChIP with H3K4me3 and
H3K27me3 antibodies, we used empty beads as negative control.
For ChIP with PPARb antibody, we considered the signal
obtained from embryos injected with PPARb MO as the negative
control. Sequences of the primers used are available upon
request.
RT-qPCR
cDNAs were obtained from 500–1000 ng of Trizol-extracted
(Invitrogen) RNA using the Quantitect kit (QIAGEN) or
SuperScript II (Invitrogen). qPCR runs were processed on an
ABI 7900 (Applied Biosystems) or on a Mx3005P (Stratagene)
instrument. For each primer pair, a mean PCR efficiency was
established a posteriori considering all of the amplification curves of
that pair, regardless of the condition (Co, MO) with the
LinRegPCR program [20]. Relative quantities were calculated
by qBase [21] using the single gene efficiency option. Sequences of
the primers used are available upon request.
Screening for H3K27me3 on the promoters of PPARb
promoted genes and control genes
PPARb-promoted genes were chosen among the top 200 most
downregulated genes upon MO injection in the list presented in
Table S1. The criteria of choice were purely technical: the ability
to obtain good primers amplifying a region in the vicinity of the
translational start. Similarly, Control genes were taken among
genes that did not show a change of expression upon MO
injection, according to the RNA-seq. ChIP were done as
explained before, but due to the low amount of material in
each sample, qPCR were done in duplicate. We considered the
tested genes as positive for H3K27me3 when the two following
criteria were met: percentage of input .1% and enrichment
over mock .5.
PPARb and Chromatin Signature of Pluripotency
PLOS ONE | www.plosone.org 2 December 2013 | Volume 8 | Issue 12 | e83300
Results and Discussion
PPARb is essential for gastrulation movements and
antero-posterior axis differentiation in Xenopus laevis
In the adult, PPARb controls many cellular processes that also
operate during development [14,24], which prompted us to
investigate its role using a dedicated model. In our eyes Xenopus
laevis presented many advantages for that study. Besides the ease of
embryo manipulation and observation it is noteworthy that
PPARb has been originally identified in that species [25]. An
important point is also that PPARb is highly expressed in the early
embryo whereas PPARa is weak and PPARc absent [25]. This led
us to speculate that a major role of PPARb would not be masked
by partially redundant actions of the two other isotypes.
We detected endogenous PPARb protein in all cell nuclei
throughout embryogenesis, with a strong increase during gastru-
lation to levels that then persisted in subsequent developmental
stages (Fig. S1C–L). This pattern of receptor protein expression
correlates with mRNA expression [25] and suggests a prominent
function for PPARb during gastrulation.
This putative role was addressed with a loss-of-function analysis
using an antisense morpholino (MO) (Fig. 1A) [26]. PPARb MO-
injected embryos showed a marked decrease in PPARb protein
levels (Fig. 1B), which correlated with a severe reduction in the
length of the anterior–posterior axis (Fig. 1C–D). These embryos
died shortly after their control siblings reached tail-bud stage. This
dramatic phenotype can be entirely attributed to the lack of
PPARb because control morpholino (Co) injection caused no
anomaly and PPARb_Rescue mRNA co-injection together with
PPARb MO restored a normal phenotype (Fig. 1C–D).
We verified that PPARb MO disrupted gastrulation movement
by selectively targeting the dorsal marginal zone with a
combination of PPARb MO or Co and fluorescent dye (Fig.
S2). At tail-bud stage, PPARb MO-injected embryos had reduced
head and neural tissues and no eyes (Fig. S3). Moreover, a
disorganized mass of cells occupied the place of the muscles, and a
cell-adhesion defect was obvious (Fig. S3). These results were
supported at neurula stage by reduced expression of marker genes
consistent with defects in brain (Krox20) and muscle (actc1,
myod1) differentiation (Fig. 2A). Of interest, PPARb already had
affected the future neural (engrailed and krox20) and muscle (actc1
and myod1) differentiation before the onset of the gastrulation
movements (Fig. 2B).
Gastrulation is a stage of intense changes in transcript
level
We evaluated the relevance of this early gastrula stage control of
differentiation marker expression by using data available from a
recent transcriptomic report [23]. We determined changes in the
level of many transcripts during normal X. laevis development.
Based on analysis of a period ranging from cleavage to the feeding
tadpole stages, the transition from mid- to late gastrula
corresponded to the stage of highest variations in individual
transcript levels, whether an increase or decrease (Fig. 3A). The
Figure 1. PPARb is essential for X. laevis development. (A) Design of the morpholino (PPARbMO) to target PPARb translation and of the control
morpholino (Co). Capital letters designate nucleotides that can hybridize with the PPARb MO. (B) Immunoblot showing endogenous PPARb levels in
non-injected embryos (Ni) and embryos injected with PPARb MO or Co. b-actin served as a loading control. (C) Scoring of A–P axis defects. Different
doses of PPARb MO, Co, or a combination of PPARb MO and PPARb_rescue mRNA were injected. Embryos with a length about a third of that of non-
injected sibling embryos were scored as ‘very-short axis’, and those with a length of about two thirds of normal were scored as ‘short axis’. (D)
Representative not-injected (Ni), Co-injected (Co), MO-injected (MO), and MO combined with rescue injected (PPARb MO + PPARb_rescue) embryos.
doi:10.1371/journal.pone.0083300.g001
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genes that were strongly activated during gastrulation maintained
their higher level of expression throughout subsequent stages
(Fig. 3B), indicating that expression changes at gastrula were not
limited to genes solely required for gastrulation itself but also
included several potential differentiation regulators.
Transcriptomic analysis of PPARb knock-down
Because of the importance of this stage in the reorganization of
the transcription profile, we analysed the impact of PPARb on the
transcriptome by RNA-seq (Fig. 4A, Table S1 and Fig. S4, and
Methods). A clear PPAR signature was revealed; most of the X.
laevis orthologs of human genes with a predicted peroxisome
proliferator-activated receptor response element were stimulated
by PPARb at mid-gastrula (Fig. 4B), suggesting conservation of
PPAR function between frogs and mammals. The RNA-seq data
also confirmed the histology and marker gene expression
presented above, i.e., PPARb promotes developmental functions
related to muscle and neural differentiation (Fig. 4C). Of
importance, neuroectoderm and mesoderm specification was not
reduced by the lack of PPARb, and the latter was even increased
dorsally (Fig. 2C–E and Fig. 4C). Thus, we excluded the possibility
that down-regulation of differentiation genes was the indirect
consequence of a lack of germ layer induction. Collectively, our
analyses identified PPARb as a major promoter of differentiation
in vivo. In support of this finding, PPARb controlled the expression
of the majority of the genes whose RNA level varies the most
between the cleavage and gastrula stages, be it a rise or a decline of
expression (Fig. 4D). In fact, this finding indicates a novel,
unsuspected role of PPARb in governing a massive wave of
transcriptional modifications initiated at early gastrulation and
affecting the later differentiation of organs such as muscle or brain.
Embryogenesis in PPARb-null mice has not been studied in detail,
possibly because defects in placenta formation may complicate the
analysis [15]; however, no gross gastrulation or differentiation
defects have been reported to date. This gap suggests that either
PPARb functions in early mouse embryogenesis are masked by
redundancy with other factors or that PPARb has specialized to
control cell differentiation in the placenta during evolution.
Chromatin signature of PPARb target genes at
gastrulation
Epigenetic mechanisms, such as those described in ESCs, could
facilitate such a coordinated broad change in the transcription
profile [5,9]. Of great interest, for many genes that PPARb
activated, the mouse orthologs are strongly activated during ESC
differentiation [3] (Fig. 4C). Moreover, PPARb also stimulated
genes, which mouse orthologs are bound by the polycomb
repressive complex that is known to deposit H3K27me3 marks
Figure 2. PPARb promotes differentiation but represses dorsal mesoderm and endoderm specification. (A)–(C) Embryos were injected
with PPARb MO or Co, allowed to develop until stage 18 (A) or stage 11.5 (B) and (D), and collected for extraction of total RNA. qRT-PCR runs for a
selection of neural (blue), mesodermal (red), or endodermal (yellow) markers of differentiation (A) and (B) or of germ layer specification (C) were
conducted. RNA levels were normalized to EEF1a and RPL8 and are presented as fold variation between MO and Co samples. Error bars represent the
S.E.M. of 3 to 5 independent experiments. (D) Embryos were injected with PPARbMO or Co, fixed at stg. 11.5, hemi-sectioned along the dorso–ventral
axis, and processed for RNA in situ hybridization. While Mo injection did not affect the sox17a expression domain, it resulted in the expansion of
brachyury expression dorsally (see the scale) but not ventrally. Arrows indicate the dorsal lip. (E) Quantification of the surface covered by the dorsal
and ventral expression domains of brachyury in MO compared to Co hemi-sections. Error bar is the S.E.M. of 10 measurements. *: two-tailed Student’s
t-test vs control, P,0.05.
doi:10.1371/journal.pone.0083300.g002
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in ESCs [3] (Fig. 4C). This association led us to hypothesize
cooperation between PPARb and epigenetic marks. We classified
X. laevis genes into two groups based on the epigenetic signatures of
mouse and/or zebrafish orthologs in pluripotent cells (Discussion
S1) [8,9]: first, the ‘K27’ group of genes, marked by H3K27me3
regardless of co-occupancy with H3K4me3, and second, the ‘K4
only’ group, marked by H3K4me3 but not by H3K27me3.
Strikingly, PPARb promoted transcription of a significant fraction
of ‘K27’ genes but of very few ‘K4 only’ genes (Fig. S5). This
finding suggested an influence of chromatin marks on PPARb
responsiveness, which was even more pronounced when we
considered only the 100 genes whose RNA level increased the
most during X. laevis gastrulation (same set of genes as in Fig. 4D).
PPARb enhanced expression of 81 of these genes, 44 of which
were ‘K27’ and 25 of which were ‘K4 only’ (Fig. S5B).
Reciprocally, PPARb repressed 71 out of the 100 most-decreased
transcripts at gastrula, and most of these repressed genes (50 genes)
were of the ‘K4 only’ class (Fig. S5B). Of note, X. laevis putative
‘K27’ genes were strongly activated very early before the end of
gastrulation while ‘K4 only’ genes were mostly maternal with high,
relatively steady RNA levels over time (Fig. S6). Because of the
possible presence of maternally inherited transcripts for the ‘K4
only’ genes, it was not possible to separate these sets of genes in
inactive and active genes at gastrulation. All together, the data
indicated that, Xenopus orthologs of ESCs genes marked by
H3K27me3 are synchronously induced at gastrula and globally
promoted by PPARb. On the contrary, Xenopus orthologs of genes
marked by H3K4me3 are globally repressed by PPARb with their
RNA level being stable or in slight decrease over gastrulation. In
ESCs, genes marked by H3K27me3 during pluripotent stage are
globally induced during ESC differentiation, while H3K4me3
genes become repressed [1]. Therefore our data show that X. laevis
gastrulation is transcriptionally closely related to ESC differenti-
ation, which was not anticipated. Is there a mechanism of
synchronous activation that is conserved in Xenopus and mouse?
Could it be that an epigenetic signature of pluripotency is
established in the course of X. laevis early development and
involves orthologs of genes marked in ESCs?
Based on present knowledge, this would be surprising because (i)
epigenetic signatures of pluripotency are poorly conserved across
species in general (even between mammals) and (ii) X. laevis is
thought to be deprived of them (Discussion S1) [27].
This prompted us to explore the possibility that H3K27me3 and
H3K4me3 are deposited during the pluripotent stages of early X.
leavis development and that PPARb cooperates with these
epigenetic marks later during gastrulation.
Identification of bivalent genes as a chromatin signature
of pluripotency in Xenopus laevis blastula
We reasoned that if epigenetic marks would be conserved
between zebrafish and mouse they might also be in X. laevis.
Therefore, to challenge the notion of a collaboration of PPARb
with epigenetic marks we started by defining a set of X. laevis genes
for which the ‘K27’ or ‘K4 only’ status of their orthologs is
conserved in both fish blastulae and mouse ESCs.
15 X. laevis genes of this set were tested for H3K27me3 and
H3K4me3 marks at different developmental stages from blastula
(pluripotent stage) to mid-gastrula. From blastula stage onwards,
both H3K27me3 and H3K4me3 marks showed a progressive
accumulation (Fig. 5A and Fig. S7), which is consistent with
previous reports [27,28]. However, in contrast to what has been
proposed [27,28], we saw no delay in H3K27me3 accumulation as
compared to H3K4me3. Of greatest importance, at stage 9 (late
blastula), our data fit very well with the predictions derived from
ESC and zebrafish blastulae (Fig. 5A). Indeed, seven of the seven
genes predicted to be ‘K27’ displayed a clear H3K27me3 signal at
this stage. These genes were also all enriched in H3K4me3,
consistent with the bivalent status of their orthologs in fish and
ESCs. Similarly, seven out of the eight predicted ‘K4 only’ genes
were indeed ‘K4 only’.
These results suggested the occurrence of bivalent genes in
frogs, in contrast to previous findings [27]. We therefore tested the
seven validated ‘K27/K4’ genes by sequential ChIP at the end of
the blastula stage (stg. 9) and found that they were all bivalent
Figure 3. Rate of transcript level variation is maximal at
gastrula stage. (A) Data from [23] were used to quantify transcription
variations during normal development. The number of genes showing
an RNA level increase or decrease by 26, 46, or 86 between two
consecutive stages was plotted. Data were normalized by the duration,
in hours, of each developmental period analysed. (B) The group of
genes with RNA levels that increased 46or more between stage 11 and
stage 13 was considered, and the RNA levels of these genes were
plotted at different developmental stages. The rectangles delineate the
25th and 75th percentiles, the horizontal bar is the median, and the
whiskers indicate the 10th and 90th percentiles.
doi:10.1371/journal.pone.0083300.g003
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(Fig. 5C). Thus, we show for the first time that X. laevis late blastula
cells resemble pluripotent ESCs and fish blastula cells with respect
to H3K4me3 and H3K27me3 marks. We conclude that this
epigenetic signature of pluripotency is present in frogs, and might
thus be a common feature of vertebrates.
H3K27me3 marks serve as cues for activation by PPARb
at gastrula
What is most important from this work is the finding that
validated ‘K27’ genes encoded transcripts that showed an abrupt
increase at gastrula stage (Fig. S6C) were promoted by PPARb at
this stage (Fig. 5A). Moreover, five of these genes are most likely
direct PPARb target genes because PPARb occupied their
chromatin at this stage (Fig. 5D). Thus, PPARb and polycomb
complex activity converge to promote transcription of early
developmental regulators at gastrulation. This conclusion raised
the question of any functional interdependence between these two
pathways. Analysis of H3K4me3 and H3K27me3 marks in
PPARb-depleted embryos revealed no major changes compared
to the control at stage 10.5 (Fig. 5A). PPARb therefore does not
affect H3K27me3 or H3K4me3 deposition, excluding the
possibility that the decreased RNA levels observed for ‘K27’
genes upon PPARb MO injection resulted from differences in the
level of activating or repressing epigenetic marks. Rather, PPARb
appears to read the epigenetic status of target genes and
preferentially activate the ‘K27’ genes.
However, this conclusion is based on only 6 X. laevis genes that
are part of a subset of ‘ultra-conserved’ genes with respect to
Figure 4. PPARb promotes the initiation of differentiation at gastrulation. (A) Rationale of the transcriptomic analysis of PPARb loss-of-
function. (B) The gene set consisting of predicted direct PPAR target genes in humans [33] was analysed by GSEA. (C) The Gene Ontology terms or the
gene sets that were significantly (FDR,0.2) affected by PPARb loss-of-function are presented. The gene sets corresponding to germ layer
specification are also presented. (D) The gene sets consisting of the 100 most-induced genes and of the 100 most-decreased genes at gastrula (see
also Fig. S5) were analysed by GSEA. FDR, false discovery rate; GSEA, Gene Set Enrichment Analysis; NES, Normalized enrichment score.
doi:10.1371/journal.pone.0083300.g004
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Figure 5. PPARb interprets a chromatin signature that is deposited at the end of the pluripotent stage. (A) Seven ‘K27’ genes and eight
‘K4 only’ genes were analysed by ChIP as indicated. Results are presented in a heat map (see also Supplementary Fig. 7). Variation in RNA expression
upon PPARb MO injection was obtained from the RNA-seq data or from qPCR validations. (B) ChIP with H3K27me3 antibody was conducted at stage
9 on 37 ‘PPARb promoted genes’ and on 27 Control genes. PPARb promoted genes were chosen among the top 200 most downregulated genes at
stage 11, upon MO injection in the list presented in Table S1, while Control genes did not show a change of expression upon MO injection. Results are
PPARb and Chromatin Signature of Pluripotency
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pluripotency signature. We thus wanted to test additional genes
with no a priori on their epigenetic state. We reasoned that if
PPARb preferentially activated K27 genes, then there should be
more K27 genes among genes that are promoted by PPARb at
gastrula than among genes that are not affected by PPARb MO.
To test this idea, we screened for the K27 mark at late blastula (see
Material and Methods) on a set of genes that are later strongly
activated by PPARb and on a set of control genes. 14 out of the 35
PPARb target genes were scored positive for K27, whereas only
one out of the 27 control genes was K27 positive (Fig.5B; Fisher
exact test, P,0.005). The low level of K27 in control genes (less
than 4%) is consistent with the low level of H3K27me3 marks
observed by mass spectrometry at this stage [29]. Finally, when
results presented in Fig. 5A and B are taken together, we have
identified 22 K27 genes on a total of 78 genes investigated, and 20
of them are promoted by PPARb. This is a clear support of our
hypothesis that PPARb collaborates with K27 mark to promote
gene expression.
To get more insights into this collaboration, we combined MO
injection with treatment of developing embryos with DZNep, a
drug that inhibits the activity of polycomb repressive complex 2 in
mammals [30]. This treatment was efficient at limiting
H3K27me3 deposition in frog embryos (Fig. 5E). At the highest
dose of DZNep, PPARb no longer promoted transcription of its
direct ‘K27’ targets genes (hoxa7, hoxa9, sox8, hoxa3, and cdx4)
(Fig. 5E). However, for evx1, which is not a PPARb direct target
gene (Fig. 5D), the indirect PPARb effect remained in spite of a
136 reduction in H3K27me3 level at this locus (Fig. 5E). Finally,
for hoxa7, hoxa2 and cdx4, PPARb binding was abrogated in the
presence of the highest dose of DZNep (Fig. 5E), which suggests
that at least for these genes, the H3K27me3 mark contributes to
the recruitment or stabilization of PPARb on their promoter
region at gastrulation.
Collectively, these data provide a proof of concept that in vivo, a
transcription factor can recognize chromatin status established at
pluripotent stage and modulate its activity accordingly: epigenetic
marks deposited at the end of the pluripotent stage (late blastula)
can influence later gene expression at gastrula under the control of
PPARb. In particular, our data challenge the interpretation that
H3K27me3 can counteract only an activating effect of the
H3K4me3 mark on bivalent genes [3,5]; instead, they show that
H3K27me3 can serve as a cue to stimulate gene transcription. At
first sight, this finding seems to contradict the well-documented
role of H3K27me3 in gene repression; however, it parallels
previous observations that in the course of mouse ESC differen-
tiation, some genes are activated even if their promoter is occupied
by polycomb proteins and clearly marked by H3K27me3 [10]. It
is also consistent with the phenotype of mice and of Xenopus
embryos lacking PRC2 function that show delayed or impaired
induction of early differentiation genes [28,31,32]. The present
works shows that X. laevis can be a model of choice to study the
relation between epigenetic marks and the switch between
pluripotency and differentiation in vivo. X. laevis blastulae and
gastrulae cells are somehow comparable to pluripotent and
differentiating ESCs, respectively. Furthermore, the identification
of PPARb as a crucial factor that interprets the chromatin
signature of pluripotency in this system could serve as a hook for
further mechanistic investigation.
Supporting Information
Figure S1 A dedicated peptide-derived antibody detects
endogenous PPARb protein throughout Xenopus laevis
early development. (A) Multiple alignments of the protein
sequences of xPPARb, xPPARa, and hPPARb/d. The region in
blue, which corresponds to the peptide used to generate the
xPPARb antibody, is not conserved. (B) DNA affinity purification
of gastrula extracts using a 36 peroxisome proliferator-activated
receptor response element biotinylated probe in the presence of
increasing concentrations of the PPARb agonist GW501516. The
lane labelled ‘‘embryo extract’’ corresponds to the input. (C)
Immunoblot showing endogenous levels of PPARb protein in total
embryo extracts. b-actin is shown as a loading control. Numbers
refer to developmental stages. The arrows mark the beginning of
the indicated phases. (D)–(L) Immunolocalization of endogenous
PPARb protein. Sections of gastrula (stg. 11; D–I) and early
tailbud (stg. 31; J–L) processed to immunolocalize endogenous
PPARb and observed by fluorescence microscopy are presented.
(D) PPARb signal. (F) DAPI signal obtained from the same section.
(H) Overlay of the PPARb and DAPI signals. (E), (G), (I), Close-
ups of (D) f, and h, respectively, showing nuclear localization.
Similarly, (J), (K), and (L) were obtained from the same section and
represent the PPARb signal, the DAPI signal, and the overlay of
both signals, respectively. Scale bar is 500 mm in (H) and (L) and
100 mm in (I).
(TIF)
Figure S2 PPARb promotes gastrulation movements. (A)
Rationale of the experiment. Eight-cell–stage embryos were
injected in one dorsal animal blastomere with a solution of
fluorescent Texas RedH dextran mixed with Co or PPARb MO.
Embryos were allowed to develop until the neurula stage, when
they were observed using a microscope set to detect Texas RedH
fluorescence (B) and (E). Embryos where then sectioned either
along a sagittal plane (C) and (F) or a transverse plane (D) and (G).
(B) and (E) represent the overlay of the bright-field and Texas
RedH channels. (C) (D) (F), and (G) images are composed with the
overlay of the DAPI (light blue), Texas RedH (red), and bright-field
(grey) channels. Scale bar is 500 mm. DMZ: dorsal marginal zone.
When gastrulation movements are well advanced, the Co-
containing cells were distributed in a narrow strip all along the
midline, as expected (B)–(D). On the contrary, PPARb MO-
containing cells were packed together with no apparent migration
phenotype (E)–(G). We conclude that PPARb promotes gastrula-
tion movements.
(TIF)
Figure S3 Histological analyses of PPARb loss-of-func-
tion embryos. (A) and (B) are sagittal sections of specimens
presented in Fig. 1d, stained with haematoxylin–eosin. (C) and (D)
PPARb MO alone (C) or combined with PPARb_rescue mRNA
(D) was injected into one blastomere of the two-cell–stage embryo
(unilateral injection). Note that the embryos unilaterally injected
with PPARb MO were curved because of an asymmetric
presented as percentage of input. The threshold of 1% is indicated. Genes scored as positive for H3K27me3 are indicated by a red dot (see methods
for further details on the definition of gene sets and on the criteria of scoring). (C) Sequential ChIPs were conducted. Note that no enrichment was
observed for klf11 and for plcg1, which represent negative controls (see panel b). Error is the S.E.M of 2 independent experiments. (D) ChIP using
PPARb antibody was conducted at stage 11.5. Error is the S.E.M of 3 to 4 independent experiments. (E) ChIP with H3K27me3 antibody or PPARb
antibody and qRT-PCR were conducted on embryos treated with DZNep or DMSO and injected with PPARb MO or Co. Error is the S.E.M of technical
replicates of a single experiment that we have replicated with similar results.
doi:10.1371/journal.pone.0083300.g005
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elongation of the A–P axis. Longitudinal sections were stained with
haematoxylin–eosin.
(TIF)
Figure S4 Validation of the transcriptomic analysis of
PPARb knockdown at mid-gastrula. (A) and (B) For 30
transcripts, the relative expression in PPARb MO vs Co obtained
from the same stage of development (11.5) was compared between
RNA-seq and qPCR. Data are presented in a table (A) and in a
correlation plot (B).
(TIF)
Figure S5 PPARb activity differs depending on putative
epigenetic marks. (A) The H3K4me3 and H3K27me3 state of
genes in mouse ESC (mESC) (2 first columns at the left [5]) or in
zebrafish (the 2 columns in the middle [8]) was used to infer a ‘K4
only’ or a ‘K27’ state of X. laevis orthologs. For these genes, the
variations in RNA level induced by PPARb depletion (RNA-seq
data) are presented as a heat map. Red genes are promoted by
PPARb while blue genes are repressed at stage 11.5. The two
columns on the right represent the genes for which the epigenetic
state is conserved between mESCs and zebrafish blastulae. (B)
Venn diagrams showing the overlap between PPARb activity,
chromatin signature (refer to the main text for the definition of the
classes), and expression profile of X. laevis genes at gastrulation.
(TIF)
Figure S6 ‘K27’ and ‘K4 only’ genes have distinct
kinetics of expression. The expression profile of ‘K27’ and
‘K4 only’ genes (see the main text for the description of the classes)
is presented at different stages of X. laevis development using data
from [23]. (A) Genes inferred from mouse ESC (mESC) data; (B)
genes inferred from zebrafish data; (C) conserved ‘K4 only’ and
‘K27’ genes in zebrafish and mESC. Bold blue lines in c
correspond to validated ‘K4 only’ genes while red lines are for
validated ‘K27’ genes. In (A) and (B) the rectangles delineate the
25th and 75th percentiles, the horizontal bar is the median, and the
whiskers indicate the 10th and 90th percentiles.
(TIF)
Figure S7 Individual data from ChIP experiments
presented in Figure 5B. ChIP data obtained with the
H3K4me3 antibody are presented in red and those obtained with
the H3K27me3 antibody are in green. Each point represents an
independent experiment.
(TIF)
Table S1.
(XLS)
Table S2.
(XLS)
Protocol S1 Functional analysis of RNA-seq data and
Most-induced and most-decreased transcripts at gas-
trulation definition.
(DOCX)
Discussion S1 Choice of epigenetic signatures of pluri-
potency.
(DOCX)
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